{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:27:12Z","timestamp":1762918032666,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UBBio Limited","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The use of deer velvet antler (DVA) as a potent traditional medicine ingredient goes back for over 2000\u2009years in Asia. Increasingly, though, DVA is being included as a high protein functional food ingredient in convenient, ready to consume products in Korea and China. As such, it is a potential source of endogenous bioactive peptides and of \u2018cryptides\u2019, i.e. bioactive peptides enzymatically released by endogenous proteases, by processing and\/or by gastrointestinal digestion. Fermentation is an example of a processing step known to release bioactive peptides from food proteins. In this study, we aimed to identify in silico bioactive peptides and cryptides in DVA, before and after fermentation, and subsequently to validate the major predicted bioactivity by in vitro analysis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Peptides that were either free or located within proteins were identified in the DVA samples by liquid chromatography-tandem mass spectrometry (LC-MS\/MS) followed by database searching. Bioactive peptides and cryptides were identified in silico by sequence matching against a database of known bioactive peptides. Angiotensin-converting enzyme (ACE) inhibitory activity was measured by a colorimetric method.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Three free bioactive peptides (LVVYPW, LVVYPWTQ and VVYPWTQ) were solely found in fermented DVA, the latter two of which are known ACE inhibitors. However matches to multiple ACE inhibitor cryptides were obtained within protein and peptide sequences of both unfermented and fermented DVA. In vitro analysis showed that the ACE inhibitory activity of DVA was more pronounced in the fermented sample, but both unfermented and fermented DVA had similar activity following release of cryptides by simulated gastrointestinal digestion.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>DVA contains multiple ACE inhibitory peptide sequences that may be released by fermentation or following oral consumption, and which may provide a health benefit through positive effects on the cardiovascular system. The study illustrates the power of in silico combined with in vitro methods for analysis of the effects of processing on bioactive peptides in complex functional ingredients like DVA.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12906-019-2758-3","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T15:02:49Z","timestamp":1575558169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["ACE inhibitory peptides in standard and fermented deer velvet: an in silico and in vitro investigation"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6652-1568","authenticated-orcid":false,"given":"Stephen R.","family":"Haines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita J.","family":"Grosvenor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ancy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alasdair","family":"Noble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Clerens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"key":"2758_CR1","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1248\/cpb.36.2587","volume":"36","author":"BX Wang","year":"1988","unstructured":"Wang BX, Zhao XH, Qi SB, Kaneko S, Hattori M, Namba T, Nomura Y. Effects of repeated administration of deer antler extract on biochemical changes related to aging in senescence-accelerated mice. Chem Pharm Bull. 1988;36:2587\u201392.","journal-title":"Chem Pharm Bull"},{"key":"2758_CR2","doi-asserted-by":"publisher","first-page":"534069","DOI":"10.1155\/2011\/534069","volume":"2011","author":"T-Y Dai","year":"2011","unstructured":"Dai T-Y, Wang C-H, Chen K-N, Huang IN, Hong W-S, Wang S-Y, Chen Y-P, Kuo C-Y, Chen M-J. The antiinfective effects of velvet antler of formosan sambar deer (Cervus unicolor swinhoei) on Staphylococcus aureus-infected mice. Evid Based Complement Alternat Med. 2011;2011:534069.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2758_CR3","first-page":"282","volume":"15","author":"ZQ Zhang","year":"1994","unstructured":"Zhang ZQ, Wang Y, Zhang H, Zhang W, Zhang Y, Wang BX. Anti-inflammatory effects of pilose antler peptide. Acta Pharmacol Sin. 1994;15:282\u20134.","journal-title":"Acta Pharmacol Sin"},{"key":"2758_CR4","unstructured":"Hemmings SJ, Song X. The effects of elk velvet antler consumption on the Fischer 344 rat: protection against CCl4-induced liver injury. In: Suttie JM, Haines SR, Li C, editors. Advances in antler science and product technology. Queenstown: Velvet Antler New Zealand Limted (Wellington, NZ); 2004. p. 211\u20139."},{"key":"2758_CR5","first-page":"151","volume":"15","author":"KW Kim","year":"1982","unstructured":"Kim KW, Park SW. A study on the hemopoietic action of deer horn extract. Korean Biochem J. 1982;15:151\u20137.","journal-title":"Korean Biochem J"},{"key":"2758_CR6","first-page":"817","volume":"36","author":"L Weng","year":"2001","unstructured":"Weng L, Zhou QL, Wang LJ, Liu YQ, Wang Y, Wang Y, Wang BX. Velvet antler polypeptides promoted proliferation of epidermic cells and fibroblasts and skin wound healing. Acta Pharm Sin. 2001;36:817\u201320.","journal-title":"Acta Pharm Sin"},{"key":"2758_CR7","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.fct.2010.02.024","volume":"48","author":"A Fraser","year":"2010","unstructured":"Fraser A, Haines SR, Stuart EC, Scandlyn MJ, Alexander A, Somers-Edgar TJ, Rosengren RJ. Deer velvet supplementation decreases the grade and metastasis of azoxymethane-induced colon cancer in the male rat. Food Chem Toxicol. 2010;48:1288\u201392.","journal-title":"Food Chem Toxicol"},{"key":"2758_CR8","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1016\/j.jchromb.2010.10.022","volume":"878","author":"L Gao","year":"2010","unstructured":"Gao L, Tao D, Shan Y, Liang Z, Zhang L, Huo Y, Zhang Y. HPLC-MS\/MS shotgun proteomic research of deer antlers with multiparallel protein extraction methods. J Chromatogr B. 2010;878:3370\u20134.","journal-title":"J Chromatogr B"},{"key":"2758_CR9","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1002\/pmic.200401027","volume":"4","author":"HJ Park","year":"2004","unstructured":"Park HJ, Lee DH, Park SG, Lee SC, Cho S, Kim HK, Kim JJ, Bae H, Park BC. Proteome analysis of red deer antlers. Proteomics. 2004;4:3642\u201353.","journal-title":"Proteomics."},{"key":"2758_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.talanta.2013.01.015","volume":"107","author":"Z Sui","year":"2013","unstructured":"Sui Z, Yuan H, Liang Z, Zhao Q, Wu Q, Xia S, Zhang L, Huo Y, Zhang Y. An activity-maintaining sequential protein extraction method for bioactive assay and proteome analysis of velvet antlers. Talanta. 2013;107:189\u201394.","journal-title":"Talanta."},{"key":"2758_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/(SICI)1097-010X(19980501)281:1<36::AID-JEZ6>3.0.CO;2-D","volume":"281","author":"SM Francis","year":"1998","unstructured":"Francis SM, Suttie JM. Detection of growth factors and proto-oncogene mRNA in the growing tip of red deer (Cervus elaphus) antler using reverse-transcriptase polymerase chain reaction (RT-PCR). J Exp Zool. 1998;281:36\u201342.","journal-title":"J Exp Zool"},{"key":"2758_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jep.2013.08.029","volume":"150","author":"L-Z Zhang","year":"2013","unstructured":"Zhang L-Z, Xin J-L, Zhang X-P, Fu Q, Zhang Y, Zhou Q-L. The anti-osteoporotic effect of velvet antler polypeptides from Cervus elaphus Linnaeus in ovariectomized rats. J Ethnopharmacol. 2013;150:181\u20136.","journal-title":"J Ethnopharmacol"},{"key":"2758_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.intimp.2013.02.027","volume":"16","author":"E Zha","year":"2013","unstructured":"Zha E, Li X, Li D, Guo X, Gao S, Yue X. Immunomodulatory effects of a 3.2 kDa polypeptide from velvet antler of Cervus nippon Temminck. Int Immunopharmacol. 2013;16:210\u20133.","journal-title":"Int Immunopharmacol"},{"key":"2758_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1082013210368461","volume":"17","author":"P Minkiewicz","year":"2011","unstructured":"Minkiewicz P, Dziuba J, Michalska J. Bovine meat proteins as potential precursors of biologically active peptides - a computational study based on the BIOPEP database. Food Sci Technol Int. 2011;17:39\u201345.","journal-title":"Food Sci Technol Int"},{"key":"2758_CR15","first-page":"71","volume":"8","author":"M Dziuba","year":"2009","unstructured":"Dziuba M, Dziuba B, Iwaniak A. Milk proteins as precursors of bioactive peptides. Acta Sci Pol Technol. 2009;8:71\u201390.","journal-title":"Acta Sci Pol Technol"},{"key":"2758_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/1082013208106320","volume":"15","author":"A Iwaniak","year":"2009","unstructured":"Iwaniak A, Dziuba J. Analysis of domains in selected plant and animal food proteins - precursors of biologically active peptides - in silico approach. Food Sci Technol Int. 2009;15:179\u201391.","journal-title":"Food Sci Technol Int"},{"key":"2758_CR17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jaoac\/91.4.965","volume":"91","author":"P Minkiewicz","year":"2008","unstructured":"Minkiewicz P, Dziuba J, Iwaniak A, Dziuba M, Darewicz M. BIOPEP database and other programs for processing bioactive peptide sequences. J AOAC Int. 2008;91:965\u201380.","journal-title":"J AOAC Int"},{"key":"2758_CR18","unstructured":"Lee Y-S. Antler herb medicine fermented with chicken gizzard and a method for preparation thereof. US Patent No. 6,482,443. USPTO; 2002."},{"key":"2758_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D Wessel","year":"1984","unstructured":"Wessel D, Fl\u00fcgge UI. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem. 1984;138:141\u20133.","journal-title":"Anal Biochem"},{"key":"2758_CR20","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1021\/jf8002009","volume":"56","author":"W Wang","year":"2008","unstructured":"Wang W, Bringe NA, Berhow MA, De Mejia EG. \u03b2-Conglycinins among sources of bioactives in hydrolysates of different soybean varieties that inhibit leukemia cells in vitro. J Agric Food Chem. 2008;56:4012\u201320.","journal-title":"J Agric Food Chem"},{"key":"2758_CR21","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1021\/ac901775h","volume":"81","author":"VK Jimsheena","year":"2009","unstructured":"Jimsheena VK, Gowda LR. Colorimetric, high-throughput assay for screening angiotensin I-converting enzyme inhibitors. Anal Chem. 2009;81:9388\u201394.","journal-title":"Anal Chem"},{"key":"2758_CR22","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1021\/pr800037n","volume":"7","author":"F Liu","year":"2008","unstructured":"Liu F, Baggerman G, Schoofs L, Wets G. The construction of a bioactive peptide database in metazoa. J Proteome Res. 2008;7:4119\u201331.","journal-title":"J Proteome Res"},{"key":"2758_CR23","doi-asserted-by":"publisher","first-page":"D933","DOI":"10.1093\/nar\/gkn823","volume":"37","author":"G Wang","year":"2009","unstructured":"Wang G, Li X, Wang Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 2009;37:D933\u2013D7.","journal-title":"Nucleic Acids Res"},{"key":"2758_CR24","unstructured":"Protein Digestion Simulator. http:\/\/omics.pnl.gov\/software\/protein-digestion-simulator. Accessed 28 February 2017."},{"key":"2758_CR25","unstructured":"ExPASy PeptideCutter. http:\/\/web.expasy.org\/peptide_cutter\/. Accessed 28 February 2017."},{"key":"2758_CR26","unstructured":"R: A language and environment for statistical computing. https:\/\/www.R-project.org. Accessed 15 June 2015."},{"key":"2758_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/(SICI)1097-0282(1997)43:2<139::AID-BIP7>3.0.CO;2-W","volume":"43","author":"RV Petrov","year":"1997","unstructured":"Petrov RV, Mikhailova AA, Fonina LA. Bone marrow immunoregulatory peptides (myelopeptides): isolation, structure, and functional activity. Biopolymers. 1997;43:139\u201346.","journal-title":"Biopolymers."},{"key":"2758_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/(SICI)1097-0282(1997)43:2<147::AID-BIP8>3.0.CO;2-V","volume":"43","author":"F Nyberg","year":"1997","unstructured":"Nyberg F, Sanderson K, Glamsta EL. The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin. Biopolymers. 1997;43:147\u201356.","journal-title":"Biopolymers."},{"key":"2758_CR29","first-page":"239","volume":"35","author":"HG Byun","year":"2002","unstructured":"Byun HG, Kim SK. Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin. J Biochem Mol Biol. 2002;35:239\u201343.","journal-title":"J Biochem Mol Biol"},{"key":"2758_CR30","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1742-1241.2006.01178.x","volume":"60","author":"A Barnett","year":"2006","unstructured":"Barnett A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int J Clin Pract. 2006;60:1454\u201370.","journal-title":"Int J Clin Pract"},{"key":"2758_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.diabet.2011.11.001","volume":"38","author":"AJ Scheen","year":"2012","unstructured":"Scheen AJ. DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials. Diabetes Metab. 2012;38:89\u2013101.","journal-title":"Diabetes Metab"},{"key":"2758_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/biot.200700045","volume":"2","author":"M Hayes","year":"2007","unstructured":"Hayes M, Stanton C, Fitzgerald GF, Ross RP. Putting microbes to work: diary fermentation, cell factories and bioactive peptides. Part II: bioactive peptide functions. Biotechnol J. 2007;2:435\u201349.","journal-title":"Biotechnol J"},{"key":"2758_CR33","first-page":"119","volume":"63","author":"IP Ashmarin","year":"1998","unstructured":"Ashmarin IP, Karazeeva EP, Lyapina LA, Samonina GE. The simplest proline-containing peptides PG, GP, PGP, and GPGG: regulatory activity and possible sources of biosynthesis. Biochem Mosc. 1998;63:119\u201324.","journal-title":"Biochem Mosc"},{"key":"2758_CR34","doi-asserted-by":"publisher","first-page":"7514","DOI":"10.1021\/jm800944x","volume":"51","author":"K K\u00e1nai","year":"2008","unstructured":"K\u00e1nai K, Ar\u00e1nyi P, B\u00f6cskei Z, Ferenczy G, Harmat V, Simon K, B\u00e1tori S, N\u00e1ray-Szab\u00f3 G, Hermecz I. Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules. J Med Chem. 2008;51:7514\u201322.","journal-title":"J Med Chem"},{"key":"2758_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1399-3011.1997.tb01156.x","volume":"49","author":"MA Castiglione Morelli","year":"1997","unstructured":"Castiglione Morelli MA, Bisaccia F, Spisani S, De Biasi M, Traniello S, Tamburro AM. Structure-activity relationships for some elastin-derived peptide chemoattractants. J Pept Res. 1997;49:492\u20139.","journal-title":"J Pept Res"},{"key":"2758_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2009.09.020","volume":"217","author":"PJ O'Reilly","year":"2009","unstructured":"O'Reilly PJ, Hardison MT, Jackson PL, Xu X, Snelgrove RJ, Gaggar A, Galin FS, Blalock JE. Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen. J Neuroimmunol. 2009;217:51\u20134.","journal-title":"J Neuroimmunol"},{"key":"2758_CR37","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.peptides.2010.06.020","volume":"31","author":"BH Sarmadi","year":"2010","unstructured":"Sarmadi BH, Ismail A. Antioxidative peptides from food proteins: a review. Peptides. 2010;31:1949\u201356.","journal-title":"Peptides."},{"key":"2758_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3177\/jnsv.55.81","volume":"55","author":"M Morifuji","year":"2009","unstructured":"Morifuji M, Koga J, Kawanaka K, Higuchi M. Branched-chain amino acid-containing dipeptides, identified from whey protein hydrolysates, stimulate glucose uptake rate in L6 myotubes and isolated skeletal muscles. J Nutr Sci Vitaminol. 2009;55:81\u20136.","journal-title":"J Nutr Sci Vitaminol"},{"key":"2758_CR39","first-page":"89","volume":"2005","author":"R Ringseis","year":"1721","unstructured":"Ringseis R, Matthes B, Lehmann V, Becker K, Sch\u00f6ps R, Ulbrich-Hofmann R, Eder K. Peptides and hydrolysates from casein and soy protein modulate the release of vasoactive substances from human aortic endothelial cells. Biochim Biophys Acta. 1721;2005:89\u201397.","journal-title":"Biochim Biophys Acta"},{"key":"2758_CR40","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/0024-3205(82)90197-7","volume":"31","author":"H Takagi","year":"1983","unstructured":"Takagi H, Shiomi H, Fukui K, Hayashi K, Kiso Y, Kitagawa K. Isolation of a novel analgesic pentapeptide, neo-kyotorphin, from bovine brain. Life Sci. 1983;31:1733\u20136.","journal-title":"Life Sci"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2758-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2758-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2758-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:18:25Z","timestamp":1607041105000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2758-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2758"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2758-3","relation":{},"ISSN":["1472-6882"],"issn-type":[{"type":"electronic","value":"1472-6882"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"30 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was supported by UBBio Limited (Christchurch, NZ), who also provided the samples of DVA and FDVA. UBBio Limited had no role in the design of the study, nor in the collection, analysis and interpretation of data, or writing the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}